Table 2 Plasma bilirubin with regard to medication and tobacco use in individuals with FEP.
Medication/tobacco | Median [Interquartile range] (n) | ||
|---|---|---|---|
Plasma bilirubin levels (µmol/l) | p valuea | ||
FEP patients on drug or on tobacco | FEP patients off drug or off tobacco | ||
Antipsychoticsb | 10.0 [10.0–13.0] (16) | 11.0 [8.0–12.0] (23) | 0.70 |
Antidepressantsc | 12.5 [10.0–16.5] (4) | 10.0 [9.0–12.0] (35) | 0.31 |
Antiepilepticsd | 8.0 (1) | 11.0 [9.0–13.0] (38) | 0.25 |
Benzodiazepinese | 12.0 [9.0–16.0] (11) | 10.5 [9.0–12.0] (28) | 0.46 |
Zopiclone | 11.0 [10.0–13.0] (10) | 10.0 [9.0–12.0] (29) | 0.18 |
Phenothiazine derivatesf | 10.0 [10.0–13.0] (11) | 11.0 [9.0–12.5] (28) | 0.73 |
Any treatmentsg | 11.0 [9.0–13.0] (27) | 10.5 [7.0–14.0] (12) | 0.62 |
Tobacco | 10.0 [9.5–11.5] (12) | 11.0 [8.5–12.5] (24) | 0.74 |